These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35367835)

  • 1. Role of FSCN1 in the tumor microenvironment of lung squamous cell carcinoma.
    Liang JS; Liu SQ; Yan CZ; Xiong M; Lin AY; Zhang X; Xiao J; Jiang W; Dong YQ
    Immunobiology; 2022 May; 227(3):152206. PubMed ID: 35367835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 inhibits migration and invasion via inhibition of fascin 1 protein expression in non-small-cell lung cancer cells.
    Zhang Y; Yang X; Wu H; Zhou W; Liu Z
    Mol Med Rep; 2015 Oct; 12(4):6193-8. PubMed ID: 26238532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSCN1 is an effective marker of poor prognosis and a potential therapeutic target in human tongue squamous cell carcinoma.
    Chen Y; Tian T; Li ZY; Wang CY; Deng R; Deng WY; Yang AK; Chen YF; Li H
    Cell Death Dis; 2019 May; 10(5):356. PubMed ID: 31043585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative Genomic and Transcriptomic Analyses of Tumor Suppressor Genes and Their Role on Tumor Microenvironment and Immunity in Lung Squamous Cell Carcinoma.
    Kim A; Lim SM; Kim JH; Seo JS
    Front Immunol; 2021; 12():598671. PubMed ID: 33717076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass Spectrometric Analysis Identifies AIMP1 and LTA4H as FSCN1-Binding Proteins in Laryngeal Squamous Cell Carcinoma.
    Gao W; An C; Xue X; Zheng X; Niu M; Zhang Y; Liu H; Zhang C; Lu Y; Cui J; Zhao Q; Wen S; Thorne RF; Zhang X; Wu Y; Wang B
    Proteomics; 2019 Nov; 19(21-22):e1900059. PubMed ID: 31287215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Value of GDF10 for the Tumorigenesis and Immune Infiltration in Lung Squamous Cell Carcinoma.
    Wang XJ; Chen JP; Qiao XW; Meng WY; Wang YW; Meng YC; Zhao R; Lin W; Liao YD; Xiao H; Mei PY
    Curr Med Sci; 2024 Apr; 44(2):309-327. PubMed ID: 38517673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. System analysis of
    Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
    Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients.
    Zhang T; Yang H; Sun B; Yao F
    Aging (Albany NY); 2021 Jan; 13(3):3819-3842. PubMed ID: 33428598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Clinical Prognostic Model for Metabolism-Related Genes in Squamous Lung Cancer and Correlation Analysis of Immune Microenvironment.
    Zhuang Z; Gao C
    Biomed Res Int; 2022; 2022():6962056. PubMed ID: 36110123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
    Deng X; Wang Z; Luo Y; Li Z; Chen L
    Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N; Li Y; Zheng P; Zhan X
    Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-200b inhibits migration and invasion in non-small cell lung cancer cells via targeting FSCN1.
    Xiao P; Liu W; Zhou H
    Mol Med Rep; 2016 Aug; 14(2):1835-40. PubMed ID: 27356635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMP12 serves as an immune cell-related marker of disease status and prognosis in lung squamous cell carcinoma.
    Zhang W; Li GS; Gan XY; Huang ZG; He RQ; Huang H; Li DM; Tang YL; Tang D; Zou W; Liu J; Dang YW; Chen G; Zhou HF; Kong JL; Lu HP
    PeerJ; 2023; 11():e15598. PubMed ID: 37601247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma.
    Shang X; Li J; Wang H; Li Z; Lin J; Chen D; Wang H
    Int Immunopharmacol; 2020 Nov; 88():106864. PubMed ID: 32866782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells.
    Liu H; Cui J; Zhang Y; Niu M; Xue X; Yin H; Tang Y; Dai L; Dai F; Guo Y; Wu Y; Gao W
    IUBMB Life; 2019 Nov; 71(11):1771-1784. PubMed ID: 31298480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Expression and Survival Significance of FOXD1 in Lung Squamous Cell Carcinoma: A Meta-Analysis, Immunohistochemistry Validation, and Bioinformatics Analysis.
    Xie F; Li Y; Liang B
    Biomed Res Int; 2022; 2022():7798654. PubMed ID: 35607308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin actin-bundling protein 1 regulates non-small cell lung cancer progression by influencing the transcription and splicing of tumorigenesis-related genes.
    Sun Q; Liu R; Zhang H; Zong L; Jing X; Ma L; Li J; Zhang L
    PeerJ; 2023; 11():e16526. PubMed ID: 38077434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
    Chen S; Giannakou A; Wyman S; Gruzas J; Golas J; Zhong W; Loreth C; Sridharan L; Yamin TT; Damelin M; Geles KG
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11671-E11680. PubMed ID: 30487219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.